Morepen Laboratories share news and announcements
NSE: MOREPENLABBSE: 500288Pharmaceuticals & BiotechnologySmall Cap
Last close ₹123.54up ₹5.87 (4.99%)BSE ₹123.25
Share price at the NSE close on 23 Oct 2026. Previous close ₹117.67.
52-week range of traded prices to 23 Oct 2026
₹33.05Low, 30 Mar 2026₹150.70High, 7 Oct 2026
- Under NSE's long-term additional surveillance, stage IV, on the list for 23 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Delivery only: shares bought must be paid for in full, with no selling on the same day.
- Next results date: the board meets on 27 Oct 2026 to consider: financial results.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹6,769 Cr1,108th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 4 Aug 2026
- 48.2
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes ₹26 crore of one-off items, the largest of them in the quarter to Sep 2025.
- 59.0
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 26 May 2026
- 5.4
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.16%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 4 Aug 2026
- 11.7%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes ₹26 crore of one-off items, the largest of them in the quarter to Sep 2025.
- 9.5%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 4 Aug 2026
- 10.3%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 26 May 2026
- 0.16
- Volume, NSEVolume. Shares traded on the last trading day.
- 50,63,581
Morepen Laboratories board meetings
128 filed, newest first. Page 1 of 3.
Oct 2026
Jul 2026
May 2026
Feb 2026
Nov 2025
Aug 2025
6 Aug · Board meeting
May 2025
Feb 2025
Jan 2025
14 Jan · Board meeting
Nov 2024
Aug 2024
27 Aug · Board meeting
12 Aug · Board meeting
May 2024
Feb 2024
22 Feb · Board meeting
19 Feb · Board meeting
Jan 2024
Oct 2023
Aug 2023
14 Aug · Board meeting
Jul 2023
May 2023
Feb 2023
2 Feb · Board meeting
Nov 2022
Jul 2022
Apr 2022
Feb 2022
8 Feb · Board meeting
Jan 2022
Nov 2021
Sep 2021
1 Sep · Board meeting
Jul 2021
Apr 2021
24 Apr · Board meeting
Mar 2021
26 Mar · Board meeting
Feb 2021
Nov 2020
9 Nov · Board meeting
Oct 2020
10 Oct · Board meeting
7 Oct · Board meeting
Aug 2020
31 Aug · Board meeting
Jun 2020
Feb 2020
14 Feb · Board meeting
Nov 2019
13 Nov · Board meeting